Global Influenza Drugs and Vaccines Market: Opportunities and Forecast (2016-2021)

Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent): Analysis By Region,

By Country: Opportunities and Forecast (2016-2021)

• By Product Type- Vaccines, Therapeutics • By Therapeutics - Relenza (Zanamivir), Tamiflu (Oseltamivir Phosphate), Rapivab (Peramivir) • By Region-North America, Europe, APAC, ROW • By Country – US, Canada, UK, France, India, China • Policy & Regulations • Pipeline Analysis

1 May 2017

Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent): Analysis By Region, By Country (2016-2021)  Scope of the Study

 Global Coverage  Regional Coverage  Country Coverage

Global Coverage

Segment Coverage  Drugs Type  Vaccines Type

 By Drugs - Zanamivir, Oseltamivir Phosphate, Peramivir  By Vaccines – Trivalent, Quadrivalent

Regional Coverage    

North America Europe Asia Pacific ROW

 Influenza Market (2011-15)  Influenza Market (2016-21)  Breakdown-By Product Type

Country Coverage

     

U.S. Canada U.K. France India China

 Therapeutics (2011-2015)  Therapeutics (2016-2021)

Company Coverage  Teva Pharmaceutical Industries Ltd.  Emergent Biosolutions  Sanofi Pasteur, Inc.  GlaxoSmithKline  Merck & Co., Inc.  CSL Limited  Astrazeneca  Pfizer  Serum Institute Of India Pvt. Ltd.  Protein Sciences Corporation

 Vaccines Market (2011-15)  Vaccines Market (2016-21)  Breakdown-By Therapeutics Type  Relenza (zanamivir)  Tamiflu (oseltamivir phosphate)  Rapivab (peramivir)  Breakdown – By Vaccine Type  Trivalent Vaccine  Quadrivalent Vaccine

 Influenza Market(2011-15)  Influenza Market (2016-21)  Influenza Market : By Product Type (2011-15)  Influenza Market : By Product Type (2016-21)

 Anti-Infective Vaccines Market (2011-15)  Anti-Infective Vaccines Market (2016-21)

 Product Benchmarking  Policy and Regulatory Landscape  Financial Analysis  Sales  Business Strategy  Market Entry Strategy

2

S.No 1.

2.

3.

Particulars

Page No.

Introduction

14

1.1.

Research Methodology

14

1.2.

Executive Summary

15

1.3.

Strategic Recommendation

16

1.3.

Product Overview

17

Global Influenza Market Overview

21

2.1.

Global Influenza Market Size, By Value, Historic, 2011-2015

22

2.2.

Global Influenza Market Size, By Value, Forecast, 2016-2021

23

Global Influenza Market, Product Analysis

24

3.1.

By Product-Actual(2015)

25

3.2.

By Product-Forecast(2021)

26

3.3.

Global Influenza Therapeutics Market , Historic, 2011-2015

27

3.4.

Global Influenza Therapeutics Market ,Forecast, 2016-2021

28

3.5.

Global Influenza Vaccines Market, Historic, 2011-2015

29

3.6.

Global Influenza Vaccines Market, Forecast, 2016-2021

30

3.7.

Global Influenza Therapeutics Market, By Drug Type

31

3.7.1.

Global Zanamivir Market , Historic, 2011-2015

32

3.7.2.

Global Zanamivir Market , Forecast, 2016-2021

33

3.7.3.

Global Oseltamivir Phosphate Market ,

Historic, 2011-2015

35

3.7.4.

Global Oseltamivir Phosphate Market , Forecast, 2016-2021

36

3.7.5.

Global Peramivir Market , Forecast, 2016-2021

38

3.8.

Global Influenza Vaccines Market, By Vaccine Type

39

3.8.1.

Global Trivalent Vaccines Market , Historic, 2011-2015

40

3.8.2.

Global Trivalent Vaccines Market , Forecast, 2016-2021

41

3.8.3.

Global Quadrivalent Vaccines Market ,

Historic, 2011-2015

43

3.8.4.

Global Quadrivalent Vaccines Market , Forecast, 2016-2021

44

(c) AZOTH Analytics

3

S.No

Particulars

Page No.

4.

Global Influenza Vaccines & Drugs - Pipeline Analysis

46

5.

Global Influenza Market, By Region

48

5.1.

By Region-Actual(2015)

49

5.2.

By Region-Actual(2021)

50

6.

7.

North America Influenza Market Overview

51

6.1.

North America Influenza Market Size, By Value, Historic, 2011-2015

52

6.2.

North America Influenza Market Size, By Value, Forecast, 2016-2021

53

6.3.

North America Influenza Therapeutics Market Size, By Value, Historic, 2011-2015

55

6.4.

North America Influenza Therapeutics Market Size, By Value, Forecast , 2016-2021

56

6.5.

North America Influenza Vaccines Market Size, By Value, Historic 2011-2015

58

6.6.

North America Influenza Vaccines Market Size, By Value, Forecast, 2016-2021

59

6.7.

North America Influenza Therapeutics: Segment Analysis

60

6.8.

North America Influenza Therapeutics Market, By Drug Type, Historic, 2011-2015

61

6.9.

North America Influenza Therapeutics Market, By Drug Type, Forecast, 2016-2021

62

6.10.

North America Influenza Vaccines: Segment Analysis

63

6.11.

North America Influenza Vaccines Market, By Vaccine Type, Historic, 2011-2015

64

6.12.

North America Influenza Vaccines Market, By Vaccine Type, Forecast, 2016-2021

65

United States Influenza Market Overview

66

7.1.

United States Influenza Market Size, By Value, Historic, 2011-2015

67

7.2.

United States Influenza Market Size, By Value, Forecast, 2016-2021

67

7.3.

United States Influenza Therapeutics Market Size, By Value, Historic 2011-2015

69

7.4.

United States Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021

69

7.5.

United States Influenza Vaccines Market Size, By Value, Historic 2011-2015

71

7.6

United States Influenza Vaccines Market Size, By Value, Forecast, 2016-2021

71

7.7.

Canada Influenza Market Size, By Value, Historic, 2011-2015

73

7.8.

Canada Influenza Market Size, By Value, Forecast, 2016-2021

73

(c) AZOTH Analytics

4

S.No

8.

9.

Particulars

Page No.

7.9.

Canada Influenza Therapeutics Market Size, By Value, Historic 2011-2015

75

7.10.

Canada Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021

75

7.11.

Canada Influenza Vaccines Market Size, By Value, Historic 2011-2015

77

7.12.

Canada Influenza Vaccines Market Size, By Value, Forecast, 2016-2021

77

7.13.

North America Other Influenza Market Size, By Value, Historic, 2011-2015

79

7.14.

North America Other Influenza Market Size, By Value, Forecast, 2016-2021

79

Europe Influenza Market Overview

80

8.1.

Europe Influenza Market Size, By Value, Historic, 2011-2015

81

8.2.

Europe Influenza Market Size, By Value, Forecast, 2016-2021

82

8.3.

Europe Influenza Therapeutics Market Size, By Value, Historic, 2011-2015

84

8.4.

Europe Influenza Therapeutics Market Size, By Value, Forecast , 2016-2021

85

8.5.

Europe Influenza Vaccines Market Size, By Value, Historic 2011-2015

87

8.6.

Europe Influenza Vaccines Market Size, By Value, Forecast, 2016-2021

88

8.7.

Europe Influenza Therapeutics: Segment Analysis

89

8.8.

Europe Influenza Therapeutics Market, By Drug Type, Historic, 2011-2015

90

8.9.

Europe Influenza Therapeutics Market, By Drug Type, Forecast, 2016-2021

91

8.10.

Europe Influenza Vaccines: Segment Analysis

92

8.11.

Europe Influenza Vaccines Market, By Vaccine Type, Historic, 2011-2015

93

8.12.

Europe Influenza Vaccines Market, By Vaccine Type, Forecast, 2016-2021

94

United Kingdom Influenza Market Overview

95

9.1.

United Kingdom Influenza Market Size, By Value, Historic, 2011-2015

96

9.2.

United Kingdom Influenza Market Size, By Value, Forecast, 2016-2021

96

9.3.

United Kingdom Influenza Therapeutics Market Size, By Value, Historic 2011-2015

98

9.4.

United Kingdom Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021

98

9.5.

United Kingdom Influenza Vaccines Market Size, By Value, Historic 2011-2015

100

9.6

United Kingdom Influenza Vaccines Market Size, By Value, Forecast, 2016-2021

100

(c) AZOTH Analytics

5

S.No 10.

11.

Particulars

Page No.

France Influenza Market Overview

101

10.1.

France Influenza Market Size, By Value, Historic, 2011-2015

102

10.2.

France Influenza Market Size, By Value, Forecast, 2016-2021

102

10.3.

France Influenza Therapeutics Market Size, By Value, Historic 2011-2015

104

10.4.

France Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021

104

10.5.

France

Influenza Vaccines Market Size, By Value, Historic 2011-2015

106

10.6.

France Influenza Vaccines Market Size, By Value, Forecast, 2016-2021

106

10.7.

Europe Other Influenza Market Size, By Value, Historic, 2011-2015

108

10.8.

Europe Other Influenza Market Size, By Value, Forecast, 2016-2021

108

APAC Influenza Market Overview

109

11.1.

APAC Influenza Market Size, By Value, Historic, 2011-2015

110

11.2.

APAC Influenza Market Size, By Value, Forecast, 2016-2021

111

11.3.

APAC Influenza Therapeutics Market Size, By Value, Historic, 2011-2015

113

11.4.

APAC Influenza Therapeutics Market Size, By Value, Forecast , 2016-2021

114

11.5.

APAC Influenza Vaccines Market Size, By Value, Historic 2011-2015

116

11.6.

APAC Influenza Vaccines Market Size, By Value, Forecast, 2016-2021

117

11.7.

APAC Influenza Therapeutics: Segment Analysis

118

11.8.

APAC Influenza Therapeutics Market, By Drug Type, Historic, 2011-2015

119

11.9.

APAC Influenza Therapeutics Market, By Drug Type, Forecast, 2016-2021

120

11.10.

APAC Influenza Vaccines: Segment Analysis

121

11.11.

APAC Influenza Vaccines Market, By Vaccine Type, Historic, 2011-2015

122

11.12.

APAC Influenza Vaccines Market, By Vaccine Type, Forecast, 2016-2021

123

(c) AZOTH Analytics

6

S.No 12.

13.

Particulars India Influenza Market Overview

Page No. 124

12.1.

India Influenza Market Size, By Value, Historic, 2011-2015

125

12.2.

India Influenza Market Size, By Value, Forecast, 2016-2021

125

12.3.

India Influenza Therapeutics Market Size, By Value, Historic 2011-2015

127

12.4.

India Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021

127

12.5.

India Influenza Vaccines Market Size, By Value, Historic 2011-2015

128

12.6.

India Influenza Vaccines Market Size, By Value, Forecast, 2016-2021

128

China Influenza Market Overview

129

13.1.

China Influenza Market Size, By Value, Historic, 2011-2015

130

13.2.

China Influenza Market Size, By Value, Forecast, 2016-2021

130

13.3.

China Influenza Therapeutics Market Size, By Value, Historic 2011-2015

132

13.4.

China Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021

132

13.5.

China Influenza Vaccines Market Size, By Value, Historic 2011-2015

134

13.6.

China Influenza Vaccines Market Size, By Value, Forecast, 2016-2021

134

13.7.

APAC Other Influenza Market Size, By Value, Historic, 2011-2015

136

13.8.

APAC Other Influenza Market Size, By Value, Forecast, 2016-2021

136

(c) AZOTH Analytics

7

S.No 14.

15.

16.

Particulars ROW Influenza Market Overview

137

14.1.

ROW Influenza Market Size, By Value, Historic, 2011-2015

138

14.2.

ROW Influenza Market Size, By Value, Historic , 2016-2021

139

Market Dynamics

140

15.1.

Drivers

140

15.2.

Challenges

145

15.3.

Trends

148

Company Profiles

153

16.1.

GlaxoSmithKline

154

16.2.

Sanofi Pasteur, Inc.

155

16.3.

CSL Limited

156

16.4.

Astrazeneca

157

16.5.

Protein Sciences Corporation

158

16.6.

Serum Institute Of India Pvt. Ltd.

159

16.7.

Emergent Biosolutions

160

16.8.

Gilead Sciences

161

16.9.

16.10.

17.

Page No.

BioCryst Pharmaceuticals.Inc.

162

Alvogen

163

About Us

164

(c) AZOTH Analytics

8

List of Figures Figure No.

Figure Title

Page No.

Figure 1:

Global Influenza Market Size, By Value, 2011-2015 (USD Billion)

22

Figure 2:

Global Influenza Market Size, By Value, 2016E-2021F (USD Billion)

23

Figure 3:

Global Influenza Market Size and Share, By Product, 2015

25

Figure 4:

Key Drivers

25

Figure 5:

Global Influenza Market Size and Share, By Product, 2021F

26

Figure 6:

Key Drivers

26

Figure 7:

Global Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion)

27

Figure 8:

Global Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion)

28

Figure 9:

Global Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)

29

Figure 10:

Global Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)

30

Figure 11:

Global Zanamivir Market Size, By Value, 2011-2015 (USD Billion)

32

Figure 12:

Global Zanamivir Market Size, By Value, 2016E-2021F (USD Billion)

33

Figure 13:

Global Oseltamivir Phosphate Market Size, By Value, 2011-2015 (USD Billion)

35

Figure 14:

Global Oseltamivir Phosphate Market Size, By Value, 2016E-2021F (USD Billion)

36

Figure 15:

Global Peramivir Market Size, By Value, 2016E-2021F (USD Billion)

38

Figure 16:

Global Trivalent Vaccines Market Size, By Value, 2011-2015 (USD Billion)

40

Figure 17:

Global Trivalent Vaccines Market Size, By Value, 2016E-2021F (USD Billion)

41

Figure 18:

Global Quadrivalent Vaccines Market Size, By Value, 2011-2015 (USD Billion)

43

Figure 19:

Global Quadrivalent Vaccines Market Size, By Value, 2016E-2021F (USD Billion

44

9

List of Figures Figure No.

Figure Title

Page No.

Figure 20:

Global Influenza Market Size and Share, By Region, 2015

49

Figure 21:

Key Drivers

49

Figure 22:

Global Influenza Market Size and Share, By Region, 2021F

50

Figure 23:

Key Drivers

50

Figure 24:

North America Influenza Market Size, By Value, 2011-2015 (USD Billion)

52

Figure 25:

North America Influenza Market Size, By Value, 2016E-2021F (USD Billion)

53

Figure 26:

North America Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion)

55

Figure 27:

North America Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion)

56

Figure 28:

North America Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)

58

Figure 29:

North America Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)

59

Figure 30:

North America Influenza Therapeutics Market: By Product, By Value, 2011-2015 (USD Billion)

61

Figure 31:

North America Influenza Therapeutics Market: By Therapeutics Type, By Value, 2016E-2021F (USD Billion)

62

Figure 32:

North America Influenza Vaccines Market: By Product Type, By Value, 2011-2015 (USD Billion)

64

Figure 33:

North America Influenza Vaccines Market: By Product, By Value, 2016E-2021F (USD Billion)

65

Figure 34:

US Influenza Market Size, By Value, 2011-2021(USD Billion)

67

Figure 35:

US Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)

69

Figure 36:

US Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)

71

10

List of Figures Figure No.

Figure Title

Page No.

Figure 37:

Canada Influenza Market Size, By Value, 2011-2021(USD Billion)

73

Figure 38:

Canada Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)

75

Figure 39:

Canada Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)

77

Figure 40:

North America Others Influenza Market Size, By Value, 2011-2021 (USD Billion)

79

Figure 41:

Europe Influenza Market Size, By Value, 2011-2015 (USD Billion)

81

Figure 42:

Europe Influenza Market Size, By Value, 2016E-2021F (USD Billion)

82

Figure 43:

Europe Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion)

84

Figure 44:

Europe Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion)

85

Figure 45:

Europe Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)

87

Figure 46:

Europe Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)

88

Figure 47:

Europe Influenza Therapeutics Market: By Product, By Value, 2011-2015 (USD Billion)

90

Figure 48:

Europe Influenza Therapeutics Market: By Therapeutics Type, By Value, 2016E-2021F (USD Billion)

91

Figure 49:

Europe Influenza Vaccines Market: By Product Type, By Value, 2011-2015 (USD Billion)

93

Figure 50:

Europe Influenza Vaccines Market: By Product, By Value, 2016E-2021F (USD Billion)

94

Figure 51:

UK Influenza Market Size, By Value, 2011-2021(USD Billion)

96

Figure 52 :

UK Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)

98

Figure 53 :

UK Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)

100

11

List of Figures Figure No.

Figure Title

Page No.

Figure 54:

France Influenza Market Size, By Value, 2011-2021(USD Billion)

102

Figure 55:

France Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)

104

Figure 56:

France Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)

106

Figure 57:

Europe Others Influenza Market Size, By Value, 2011-2021 (USD Billion)

108

Figure 58:

APAC Influenza Market Size, By Value, 2011-2015 (USD Billion)

110

Figure 59:

APAC Influenza Market Size, By Value, 2016E-2021F (USD Billion)

111

Figure 60:

APAC Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion

113

Figure 61:

APAC Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion)

114

Figure 62:

APAC Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)

116

Figure 63:

APAC Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)

117

Figure 64:

APAC Influenza Therapeutics Market: By Product, By Value, 2011-2015 (USD Billion)

119

Figure 65:

APAC Influenza Therapeutics Market: By Therapeutics Type, By Value, 2016E-2021F (USD Billion)

120

Figure 66:

APAC Influenza Vaccines Market: By Product Type, By Value, 2011-2015 (USD Billion)

122

Figure 67:

APAC Influenza Vaccines Market: By Product, By Value, 2016E-2021F (USD Billion)

123

Figure 68:

India Influenza Market Size, By Value, 2011-2021(USD Billion)

125

Figure 69:

India Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)

127

Figure 70:

India Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)

128

12

List of Figures Figure No.

Figure Title

Page No.

Figure 71:

China Influenza Market Size, By Value, 2011-2021(USD Billion)

130

Figure 72:

China Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion)

132

Figure 73:

China Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion)

134

Figure 74:

APAC Others Influenza Market Size, By Value, 2011-2021 (USD Billion)

136

Figure 75:

ROW Influenza Market Size, By Value, 2011-2015 (USD Million)

138

Figure 76:

ROW Influenza Market Size, By Value, 2016E-2021F (USD Million)

139

Table A:

Influenza Pipe analysis

46

Table B:

Influenza Pipe analysis

47

13

Global Influenza Market- Product Analysis Rising number of cases around the globe along with rising awareness regarding the drug have been propelling the market for influenza vaccination.

Figure : Global Influenza Market Size and Share,

By Product, 2015

Figure : Key Drivers

14.83% Vaccines

Therapeutics

85.17%

Source: Azoth Analytics

14

Global Influenza Vaccines Market Rising affordability of the population along with increasing awareness among them and development of a global vaccine is anticipated to drive the market in the forecast period.

Figure : Global Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion) CAGR: xxx%

2016E

2017F

2018F

2019F

2020F

2021F

Source: Azoth Analytics Estimates xxxx xxxxx xxxxx Xxxx •

.

Xxxx xxxx

15

North America Influenza Therapeutics Market Figure 31: North America Influenza Therapeutics Market: By Therapeutics Type, By Value, 2016E-2021F (USD Billion)

2016E

2017F

2018F Zanamivir

2019F Oseltamivir phosphate

2020F

2021F

Peramivir

CAGR 2016E-2021F Zanamivir: x% , Oseltamivir Phosphate: x%, Peramivir: x% Source: Azoth Analytics Estimates

Xx Xx Xx Xx xx

16

France Influenza Market Overview France Influenza Market is witnessing growth due to high penetration of vaccines and drugs in this country as compared to other less developed countries.

Figure : France Influenza Market Size, By Value, 2011-2021(USD Billion) CAGR: xxx%

CAGR: xxx%

2011

2012

2013

2014

2015

2016E

2017F

2018F

2019F

2020F

2021F

Source: Azoth Analytics Estimates xxxx xxxxx xxxx xxxx •

.

xxxxx

17

APAC Others Influenza Market Overview The changed perception of the general population and continuous improvements in the formulations of the vaccines and drugs is leading to the growth of this market.

Figure : APAC Others Influenza Market Size, By Value, 2011-2021 (USD Billion)

CAGR:xxx%

0.130

0.144

0.159

2011

2012

2013

CAGR: xxx%

0.174

0.188

0.217

0.246

0.275

2014

2015

2016E

2017F

2018F

0.304

0.334

0.364

2019F

2020F

2021F

Source: Azoth Analytics Estimates xxxx xxxx xxxx xxxxx xxxxx •

.

xxxxx

18

Research Methodology For our study on Global Influenza Drugs and Vaccines Market , we have conducted comprehensive secondary research followed by an extensive primary research. In the process of secondary research, we have scrutinized industry documents, accessed from open sources, premium paid databases (Bloomberg, Thomson Reuters, Factiva) and our internal knowledge base. In the process of primary research, we have interviewed various industry experts across the value chain of the Influenza Drugs and Vaccines Market .

Market size of the actual period (2011-2016) has been evaluated on the basis of growth trends of the industry in the last five years, and confirming the findings through primary research. Annual reports of the companies are scanned to further validate the market size and to estimate the size of various other end-user sectors. Market sizing and growth in the forecast period (2017-2022) is estimated through product mapping, application in end-user industries, growth of allied sectors and historical growth pattern of the industry. All the relevant data points/ statistics in the forecast period are validated through relevant and reliable primary sources.

Report Focus: Global Influenza Drugs and Vaccines Market -By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), -By Vaccine (Trivalent, Quadrivalent) -By Region (North America, Europe, APAC, ROW), -By Country (U.S., Canada, U.K., Germany, France, China, India, Japan) -Company Analysis - Falvogen, Gilead Science and Bio Cryst

19

Report Ordering Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021)- - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, China, India, Japan)

Publish Date: May 2017 No. of Pages:164 Price: USD 2000 (Single User License) Price: USD 3000 (Multi- User License)

To View Sample Report or Purchase Report Click Here

Contact Us ASIA PACIFIC

EUROPE

Mail: info@azothanalytics.com Phone: +91 120 429 8235 NORTH AMERICA

Mail: shipra@azothanalytics.com Phone: +44 - 744 - 8107625 Call for Assistance

Mail: tanvi@azothanalytics.com Phone: +1 - 321 - 444 9707

Phone: +91 9873 4262 88 Sales Enquiry Phone: +91 120 429 8235

www.azothanalytics.com

20